D-0086-2019 Class II Terminated

Recalled by Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

FDA drug recall D-0086-2019 was initiated by Valeant Pharmaceuticals North America LLC on Aug 24, 2018 and is designated Class II. Reason for recall: CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the… The recall status is terminated (terminated Mar 6, 2020). Affected quantity: 5,016 tubes.

Recall details

Product Type
Drugs
Report Date
Oct 31, 2018
Initiation Date
Aug 24, 2018
Termination Date
Mar 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,016 tubes

Product description

Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. (42 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875519155

Reason for recall

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Distribution pattern

Product was distributed throughout the United States

Code information

Lot #: 172185F, Exp 6/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0086-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0086-2019. Report a data issue: hello@regdatalab.com.